DATA SHEET - Medsafe
DATA SHEET NEISVAC-C® Meningococcal group C polysaccharide conjugate vaccine (tetanus toxoid protein conjugate) COMPOSITION Active ingredient: each 0.5mL dose contains 10 micrograms of meningococcal polysaccharide
Download DATA SHEET - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Vaccinations 101 - ABRL
www.abrl.orgVaccinations 101 Article by Lisa Rodier from Whole Dog Journal, August 2008 Vaccines are something that every dog owner should be educated about, and yet few seem to
1. CURRENT STATUS AND NEW TRENDS IN …
www.bvv.sld.cu1 VacciMonitor 2009; Vol. 18 Año 1 Suppl. 1 ABSTRACTS Traditionally, animal models have played a significant role in quality control of vaccines.
MEDIA RELEASE - Department of Health
www.health.gov.auTHE HON SUSSAN LEY MP Minister for Health Minister for Sport MEDIA RELEASE 11 February 2015 Leading medical researcher to head the NHMRC Distinguished medical researcher, Professor Anne Kelso AO, has been appointed the
VACCINE INFOR MATION - Department of Health
www.kznhealth.gov.zaFOR PARENTS & CAREGIVERS VACCINE INFOR MATION NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES Division of the National Health Laboratory Service First Edition November 2016
Microbiology 532 Immunology Examination KEY …
www.umich.eduMicrobiology 532 Immunology Examination page 2 of 7 6. Adoptive-acquired immunity may be the result of: Correct a. transfer of bone marrow from one individual to another. b. immunization with a vaccine.
Guidelines on the nonclinical evaluation of vaccine ...
www.who.intPage 5 Introduction This document provides guidance to national regulatory authorities (NRAs) and manufacturers on the nonclinical and initial clinical evaluation of vaccine adjuvants and adjuvanted vaccines by
Claire-Anne Siegrist - WHO
www.who.intVaccine Immunology 17 2 Continued on following page BOX 2.1 Main Immunological Definitions ADJUVANT Agents that increase the stimulation of the immune system by
eneral Recommendations on Immuniation
www.cdc.goveneral Recommendations on Immuniation 9 2 This chapter discusses issues that are commonly encountered in vaccination practice. A more thorough discussion of issues common to more than one vaccine can
Related search queries
Vaccinations 101, Quality control of vaccines, MEDIA RELEASE, VACCINE INFOR MATION, Microbiology 532 Immunology Examination KEY, Microbiology 532 Immunology Examination, Vaccine, Guidelines on the nonclinical evaluation, Vaccine adjuvants and adjuvanted vaccines, Vaccine Immunology, Eneral Recommendations on Immuniation